Drug Discovery News Acknowledges Our Efforts
In an ongoing flurry of recognition of our efforts to support the discovery of new cures for Tuberculosis, and our related funding from the Bill and Melinda Gates Foundation (as announced here) the Informatics arm of the Drug Discovery News web portal has acknowledged our work.
They interviewed Ken Duncan, a senior program officer at the Gates Foundation who commented “CDD’s technology will help the entire TB research community to collaborate more easily,” Duncan said in the statement. “We hope it will speed the scientific breakthroughs urgently needed to make effective therapies more accessible to the world’s poorest people, and confront the challenges of multidrug- and extensively drug-resistant TB strains.” Ken has certainly captured the spirit of what we are working to achieve with the development of the CDD platform.
They also interviewed our own Sean Ekins who had the opportunity to emphasize how our approach can change the classical ways of interacting. As Sean comments in the interview, “…how can some academics share modules with someone who wants to do testing, and how can we connect those two groups of people together without the tried-and-tested way of looking for each other on Google, PubMed or a conference?”. We certainly believe that CDD can make a difference in this direction and certainly execute on our ultimate vision.
As Sean says “Our ultimate goal is to advance a couple of new, key TB drug candidates. That is a lofty goal, but we’re hoping to pull it off within two years.” if you are interested in helping in this venture feel free to contact us.